London & Capital Asset Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
London & Capital Asset Management's AMGN Position: Q2 2026 in Review
London & Capital Asset Management sold out of Amgen (AMGN) in Q2 2026, closing a stake of 717 shares — an estimated $252K sold.
London & Capital Asset Management first reported a position in AMGN in Q4 2018 and held it in 26 quarters. The position peaked at $43.4M in Q4 2023. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- London & Capital Asset Management reported no remaining Amgen position as of Q2 2026 after selling out during the quarter.
- London & Capital Asset Management sold 717 Amgen shares in Q2 2026, an estimated $252K.
- London & Capital Asset Management first reported a position in Amgen in Q4 2018 and held it in 26 quarters.
- London & Capital Asset Management's Amgen position peaked at $43.4M in Q4 2023.
- 3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on London & Capital Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.